AGIO
$56.18
Agios Pharmaceuticals
$.43
.77%
AGIO
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($1.39)
Revenue:  $18.80 Mil
Thursday
Jul 29
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AGIO reports earnings?
Beat
Meet
Miss

Where is AGIO's stock price going from here?
Up
Flat
Down
Stock chart of AGIO
Analysts
Summary of analysts' recommendations for AGIO
Score
Grade
Pivots
Resistance
$60.84
$58.65
$57.41

$55.22

Support
$53.98
$51.79
$50.55
Tweet
Growth
Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsUltragenyx PharmaceuticalBristol-Myers SquibbPfizerZoetisEli LillyMerck & Co.